Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDT-10013 for Acute Postoperative Pain Following Bunionectomy
NCT02077140Phase 2Completed
- Sponsor
- Medtronic
- Start
- Feb 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of MDT-10013 in postoperative pain, sponsored by Medtronic. Primary endpoint: Summed Pain Intensity Over 1-48hrs. Started Feb 2014; status: completed.
02
Drugs
MDT-10013
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02077140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077140.